HM Payson & Co
- SEC CIK
- 0000928052
- Latest filing
- Jul 17, 2026
GILD holding history
Gilead Sciences, Inc. in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GILD overviewAll 13F holders of GILDFull Q2 2026 holdings
- Shares (Q2 2026)
- 7,060
- Value
- $892.0K
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 7,060 | $892.0K | <0.1% | −376−5.1% | Reduced | Holders |
| Q1 2026 | 7,436 | $1.04M | <0.1% | +376+5.3% | Added | Holders |
| Q4 2025 | 7,060 | $866.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 7,060 | $783.7K | <0.1% | +1,003+16.6% | Added | Holders |
| Q2 2025 | 6,057 | $671.5K | <0.1% | −10.0% | Reduced | Holders |
| Q1 2025 | 6,058 | $678.8K | <0.1% | +527+9.5% | Added | Holders |
| Q4 2024 | 5,531 | $510.9K | <0.1% | −18−0.3% | Reduced | Holders |
| Q3 2024 | 5,549 | $465.2K | <0.1% | −1,677−23.2% | Reduced | Holders |
| Q2 2024 | 7,226 | $495.8K | <0.1% | +915+14.5% | Added | Holders |
| Q1 2024 | 6,311 | $462.3K | <0.1% | −101−1.6% | Reduced | Holders |
| Q4 2023 | 6,412 | $519.4K | <0.1% | −769−10.7% | Reduced | Holders |
| Q3 2023 | 7,181 | $538.1K | <0.1% | +200+2.9% | Added | Holders |
| Q2 2023 | 6,981 | $538.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 6,981 | $579.2K | <0.1% | +500+7.7% | Added | Holders |
| Q4 2022 | 6,481 | $556.4K | <0.1% | −940−12.7% | Reduced | Holders |
| Q3 2022 | 7,421 | $458.0K | <0.1% | +900+13.8% | Added | Holders |
| Q2 2022 | 6,521 | $403.0K | <0.1% | −326−4.8% | Reduced | Holders |
| Q1 2022 | 6,847 | $407.0K | <0.1% | −1,024−13.0% | Reduced | Holders |
| Q4 2021 | 7,871 | $571.0K | <0.1% | −1,310−14.3% | Reduced | Holders |
| Q3 2021 | 9,181 | $641.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 9,181 | $632.0K | <0.1% | −35−0.4% | Reduced | Holders |
| Q1 2021 | 9,216 | $596.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.